BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 17663504)

  • 1. Veno occlusive disease: update on clinical management.
    Senzolo M; Germani G; Cholongitas E; Burra P; Burroughs AK
    World J Gastroenterol; 2007 Aug; 13(29):3918-24. PubMed ID: 17663504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
    Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
    Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transjugular Intrahepatic Portosystemic Shunt for Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-transplantation Cyclophosphamide.
    Gómez-Centurión I; Bailén R; Oarbeascoa G; Muñoz C; Luque AÁ; Boyra ME; Calleja E; Rincón D; Dorado N; Barzallo P; Anguita J; Díez-Martín JL; Kwon M
    Biol Blood Marrow Transplant; 2020 Nov; 26(11):2089-2097. PubMed ID: 32791193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of defibrotide in the treatment and prevention of veno-occlusive disease.
    Richardson P; Linden E; Revta C; Ho V
    Expert Rev Hematol; 2009 Aug; 2(4):365-76. PubMed ID: 21082942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful defibrotide treatment of a patient with veno-occlusive disease after living-donor liver transplantation: A case report.
    Lee TB; Yang K; Ko HJ; Shim JR; Choi BH; Lee JH; Ryu JH
    Medicine (Baltimore); 2021 Jun; 100(25):e26463. PubMed ID: 34160449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.
    Corbacioglu S; Kernan N; Lehmann L; Brochstein J; Revta C; Grupp S; Martin P; Richardson PG
    Expert Rev Hematol; 2012 Jun; 5(3):291-302. PubMed ID: 22780209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Veno-occlusive disease--an important complication in hematopoietic cells transplantation].
    Skotnicki AB; Krawczyk J
    Przegl Lek; 2001; 58(11):995-9. PubMed ID: 11987843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Outcome of Veno-Occlusive Disease After Liver Transplant: A Retrospective Single-Center Experience.
    Patrono D; Marola S; David E; Chiusa L; Martini S; Mirabella S; Lupo F; Salizzoni M; Romagnoli R
    Exp Clin Transplant; 2019 Apr; 17(2):214-221. PubMed ID: 30381049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions for prophylaxis of hepatic veno-occlusive disease in people undergoing haematopoietic stem cell transplantation.
    Cheuk DK; Chiang AK; Ha SY; Chan GC
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD009311. PubMed ID: 26017019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study.
    Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Shore T; Iacobelli M; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ;
    Biol Blood Marrow Transplant; 2017 Jun; 23(6):997-1004. PubMed ID: 28285079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome.
    Richardson PG; Murakami C; Jin Z; Warren D; Momtaz P; Hoppensteadt D; Elias AD; Antin JH; Soiffer R; Spitzer T; Avigan D; Bearman SI; Martin PL; Kurtzberg J; Vredenburgh J; Chen AR; Arai S; Vogelsang G; McDonald GB; Guinan EC
    Blood; 2002 Dec; 100(13):4337-43. PubMed ID: 12393437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic stem cell transplantation: Middle East/North Africa regional consensus on prevention, diagnosis and management.
    Al Jefri AH; Abujazar H; Al-Ahmari A; Al Rawas A; Al Zahrani Z; Alhejazi A; Bekadja MA; Ibrahim A; Lahoucine M; Ousia S; Bazarbachi A
    Bone Marrow Transplant; 2017 Apr; 52(4):588-591. PubMed ID: 27892944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children.
    Qureshi A; Marshall L; Lancaster D
    Pediatr Blood Cancer; 2008 Apr; 50(4):831-2. PubMed ID: 18286502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic veno-occlusive disease after bone marrow transplant.
    Carreras E; Grañena A; Rozman C
    Blood Rev; 1993 Mar; 7(1):43-51. PubMed ID: 8467232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Veno-occlusive disease of the liver after hemopoietic cell transplantation.
    Carreras E
    Eur J Haematol; 2000 May; 64(5):281-91. PubMed ID: 10863974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation.
    Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ
    Br J Haematol; 2017 Jul; 178(1):112-118. PubMed ID: 28444784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defibrotide: a review of its use in severe hepatic veno-occlusive disease following haematopoietic stem cell transplantation.
    Keating GM
    Clin Drug Investig; 2014 Dec; 34(12):895-904. PubMed ID: 25351934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of defibrotide in blood and marrow transplantation.
    Richardson PG; Carreras E; Iacobelli M; Nejadnik B
    Blood Adv; 2018 Jun; 2(12):1495-1509. PubMed ID: 29945939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies.
    Ho VT; Revta C; Richardson PG
    Bone Marrow Transplant; 2008 Feb; 41(3):229-37. PubMed ID: 17994121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transjugular intrahepatic portosystemic shunting (TIPS) for treatment of severe hepatic veno-occlusive disease.
    Smith FO; Johnson MS; Scherer LR; Faught P; Breitfeld PP; Albright E; Hillier SC; Gowan D; Smith PD; Robertson KA; Emanuel D
    Bone Marrow Transplant; 1996 Sep; 18(3):643-6. PubMed ID: 8879632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.